First I should declare I am the most novice, inexperienced, ill-informed and grammatically incompetent veiwer of this forum and as such, any following barrage is most likely deserved.
I have followed MSB since 2009, as a stupid 22yo who herniated a lumbar disc playing rugby, I was looking for the future of medicine to be then when i needed it.
However, the reality is clinical trials and licensing can be a 8-15 year journey which Imo MSB have endured as best as any company could.
Further, they have worked on multiple products allowing for multiple income streams in a growing market and with no real competition? Is that correct?
I have followed the forum since August and the recent movement in the company and have used my savings i am willing to risk and commited my support to this company in hope of a return in the near future.
I have the upmost respect for the long term holders and believers.
I have a couple questions that will most likely sound stupid. however,
given the current correction in the market, MSB has weathered quite well.
Do people think the November conference has been priced in?
conservatively, how many more years will it be till the stage 3 products will be on market.
apologies for my nonsense.
MSB Price at posting:
$2.06 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)